vTv Therapeutics: Samsara proposes $1.32M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
vTv Therapeutics Inc. (VTVT) is the issuer in a notice listing a proposed sale by shareholder Samsara BioCapital, L.P. of 61,287 common shares, with an aggregate market value of $1,315,831.89 and an approximate sale date of November 12, 2026. Merrill Lynch is listed as broker. The notice lists 4,011,465 common shares outstanding.
Key Figures
Key Terms
Aggregate Market Value financial
Private Placement financial
Warrant Exercise financial
Net Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.